Litcius/Paper detail

Continuation of immunotherapy beyond progression is beneficial to the survival of advanced non-small-cell lung cancer

Yuanyuan Cheng, Zhe Ye, Yanru Xie, Xuedan Du, Siqi Song, Xiaobo Ding, Chuchu Lin, Bin Wang, Wenfeng Li, Chunhong Zhang

2023Clinical & Translational Oncology13 citationsDOI

Topics & Concepts

MedicineDiscontinuationImmunotherapyInternal medicineLung cancerChemotherapyOncologySurgeryCancerCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Diagnosis and Treatment
Continuation of immunotherapy beyond progression is beneficial to the survival of advanced non-small-cell lung cancer | Litcius